ImmunityBio, Inc

IBRXNASDAQ · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

1.05B

on 2026-06-30, from 677.0M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

S-3ASR of 2024-04-17. Not read yet. S-3ASR ↗

$460.0M

Agreement of 2025-12-29. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

47.86M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

5.1 quarters

$357.4M on 2026-06-30 ÷ $70.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-07-24	Private placement	not read	not read	$80.0M	8-K ↗
2025-07-24	Registered direct offering	29,629,632	not read	$80.0M	424B5 ↗
2025-04-07	Private placement	not read	not read	$75.0M	8-K ↗
2025-04-07	Public offering	29,024,768	not read	$75.0M	424B5 ↗